Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: RIG 101 Trial in Healthy Adults and Adults With Asthma [Phase 1, Phase 2]

View source ↗

Summary

RIGImmune Inc. reports that the Phase 1/2 trial of RIG 101 in healthy adults and adults with asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIG 101 (RIG-101)

Snippet

Sponsor: RIGImmune Inc. | Conditions: Healthy Adult Participants, Asthma Exacerbation | Phase 1, Phase 2 | Status: RECRUITING